SIM
NVS icon

Seaview Investment Managers’s Novartis NVS Stock Holding History

Seaview Investment Managers’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-100,478
Closed -$11.2M – 145
2025
Q1 		$11.2M Buy
100,478
+3,147
+3% +$335K 2.72% 14
2024
Q4 		$9.47M Buy
97,331
+14,518
+18% +$1.55M 2.62% 21
2024
Q3 		$9.53M Sell
82,813
-5,612
-6% -$637K 2.87% 16
2024
Q2 		$9.41M Sell
88,425
-487
-0.5% -$48.9K 2.83% 21
2024
Q1 		$8.6M Buy
+88,912
New +$9.12M 2.59% 17

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Seaview Investment Managers's NVS Position: Q2 2025 in Review

Seaview Investment Managers sold out of Novartis (NVS) in Q2 2025, closing a stake of 100,478 shares — an estimated $11.2M sold.

Seaview Investment Managers first reported a position in NVS in Q1 2024 and held it in 5 quarters. The position peaked at $11.2M in Q1 2025. 1,383 funds tracked by Wall St. Rank hold NVS as of Q2 2025.

  • Seaview Investment Managers reported no remaining Novartis position as of Q2 2025 after selling out during the quarter.
  • Seaview Investment Managers sold 100,478 Novartis shares in Q2 2025, an estimated $11.2M.
  • Seaview Investment Managers first reported a position in Novartis in Q1 2024 and held it in 5 quarters.
  • Seaview Investment Managers's Novartis position peaked at $11.2M in Q1 2025.
  • 1,383 funds tracked by Wall St. Rank held Novartis as of Q2 2025.

Based on Seaview Investment Managers's 13F filing for Q2 2025, filed 12 Aug 2025.